Artigo
Revisado por pares
A phase II trial of weekly 1-hour paclitaxel as second-line therapy for endometrial and cervical cancer
2008; Springer Science+Business Media; Volume: 13; Issue: 1 Linguagem: Inglês
10.1007/s10147-007-0731-5
ISSN1437-7772
AutoresHoward D. Homesley, Nathan P. Meltzer, Lucybeth Nieves, Luis Vaccarello, George S. Lowendowski, Al Elbendary,
Tópico(s)Lymphoma Diagnosis and Treatment
Referência(s)